THE OVERVIEW OF STUDIES ON HUPERZINE A: A NATURAL DRUG FOR THE TREATMENT OF ALZHEIMER’S DISEASE - Medicinal Chemistry of Bioactive Natural Products - page 181

134. Pang, Y. P.; Quiram, P.; Jelacic, T.; Hong, F.; Brimijoin, S. Highly potent, selective, and
low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. J. Biol. Chem.,
1996, 271: 23646-23649.
135. Carlier, P. R.; Du, D. M.; Han, Y. F.; Liu, J.; Perola, E.; Williams, I. D.; Pang, Y. P.
Dimerization of an inactive fragment of huperzine A produces a drug with twice the
potency of the natural product. Angew. Chem. Int. Ed. Engl., 2000, 39(10): 1775-1777.
136. Jin, G. Y.; He, X. C.; Zhang, H. Y.; Bai, D. L. Synthesis of alkylene-linked dieters of
( )-huperzine A. Chinese Chem. Lett., 2002, 13(1): 23-26.
137. Jin, G. Y.; Luo, X. M.; He, X. C.; Jiang, H. L.; Zhang, H. Y.; Bai, D. L. Synthesis and
docking studies of alkylene-linked dimers of ( )-huperzine A. Arzneimittel-Forsch,
2003; 53(11): 753-757.
138. Zeng, F. X.; Jiang, H. L.; Yang, Y. S.; Liu, D. X.; Zhang, H. Y.; Chen, K. X.; Ji, R. Y.
Synthesis and pharmacological study of huperzine A-E2020 combined compound. Acta
Chim. Sin., 2000, 58(5): 580-587.
139. Liu, J.; Zhang, H. Y.; Wang, L. M.; Tang, X. C. Inhibitory effects of huperzine B on
cholinesterase activity in mice. Acta Pharmacol. Sin., 1999, 20(2): 141-145.
140. Rajendran, V.; Rong, S. B.; Saxena, A.; Doctor, B. P.; Kozikowski, A. P. Synthesis of a
hybrid analog of the acetylcholinesterase inhibitors huperzine A and huperzine B.
Tetrahedron Lett., 2001, 42(32): 5359-5361.
141. Rajendran, V.; Saxena, A.; Doctor, B. P.; Kozikowski, A. P. Synthesis of more potent
analogues of the acetylcholinesterase inhibitor, huperzine B. Bioorg. Med. Chem. Lett.,
2002, 12(11): 1521-1523.
142. Camps, P.; Contreras, J.; Font-Bardia, M.; Morral, J.; Munoz-Torrero, D.; Solans, X.
Enantioselective synthesis of tacrine-huperzine A hybrids. Preparative chiral MPLC
separation of their racemic mixtures and absolute configuration assignments by x-ray
diffraction analysis. Tetrahedron-Asymmetry, 1998, 9(5): 835-849.
143. Camps, P.; El Achab, R.; Gorbig, D. M.; Morral, J.; Munoz-Torrero, D.; Badia, A.;
Banos, J. E.; Vivas, N. M.; Barril, X.; Orozco, M.; Luque, F. J. Synthesis in vitro
pharmacology and molecular modeling of very potent tacrine-huperzine A hybrids as
acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's
disease. J. Med. Chem., 1999, 42(17): 3227-3242.
144. Raves, M. L.; Harel, M.; Pang, Y. P.; Silman, I.; Kozikowski, A. P.; Sussman, J. L.
Structure of acetylcholinesterase complexed with the nootropic alkaloid, ( )-huperzine
A. Nat. Struct. Biol., 1997, 4(1): 57-63.
145. Ashani, Y.; Peggins, J. O.; Doctor, B. P. Mechanism of inhibition of cholinesterases by
huperzine-A. Biochem. Biophys. Res. Commun., 1992, 184(2): 719-726.
146. Saxena, A.; Qian, N. F.; Kovach, I. M.; Kozikowski, A. P.; Pang, Y. P.; Vellom, D. C.;
Radic, Z.; Quinn, D.; Taylor, P.; Doctor, B. P. Identification of amino-acid-residues
involved in the binding of huperzine-A to cholinesterases. Protein Sci., 1994, 10: 1770-
1778.
147. Sussman, J. L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I.
Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic

acetylcholine-binding protein. Science, 1991, 253: 872-879.
148. Isralewitz, B.; Gao, M.; Schulten, K. Steered molecular dynamics and mechanical
functions of proteins. Curr. Opin. Struc. Biol., 2001, 11: 224-230.